Many experts now view chronic weight management like chronic hypertensionrequiring continuous medication for sustained results
Zepbound leads on reality: it is FDA-approved, prescribable, and available right now, while retatrutide remains in Phase 3 and cannot be legally filled for weight loss as of June 2026
Adherence is generally affected by a combination of capability (strength, dexterity, cognitive powers), opportunity (complexity, cost, availability) and motivation (intrinsic drivers, rewards, general mood).11 Based on this, it is possible to calculate relative differences in likely adherence with a quantitative analysis of typical disease impact, patient demographics, drug effects and device operating principles.12 By systematically analysing a drug delivery solution, it is possible to identify opportunities for improvement and determine the cost-benefit of investing in a wide range of design features
PMC Review: PMC5741312 Molecular Immunology (2023) Volume 159 Identified and confirmed TRPV1 channel inhibition as a second, direct analgesic mechanism of ARA-290, separate from IRR-mediated anti-inflammatory activity
